(lp0
S'Market: The Suntrust Banks Inc. Raises Stake in Repligen Corporation  Petro Global News 24 - Jan 26, 2017 A number of other hedge funds and other institutional investors have also added to or reduced their stakes in RGEN. Conestoga Capital Advisors LLC increased its position in Repligen Corporation by 3.5% in the third quarter. Conestoga Capital Advisors ...'
p1
aS'35.35 MarketWatch - Nov 16, 2010 Jan. 13, 2017 at 10:30 a.m. ET; on Seeking Alpha. Repligen Corporation  Presents At 35th Annual J.P. Morgan Healthcare Conference.'
p2
aS"3 Important Things You Need to Know About Repligen Corporation's Q3 Results Motley Fool - Nov 3, 2016 It's been an up-and-down year so far in 2016 for Repligen Corporation . Repligen's stock price is close to where it was in January despite plenty of big moves along the way."
p3
aS'Repligen Corporation  Breaks into New 52-Week High on April 13 Session Equities.com - Apr 13, 2017 Shares of Repligen Corporation  broke into a new 52-week high yesterday, hitting a peak of $35.75. Shares closed at $35.35 after opening at $35.08 for a move of 0.6%.Repligen Corporation  Reviewed By Analysts - The De Soto EdgeRepligen  Reaches $35.14 After 4.00% Up Move; Berkshire Hathaway Raised ... - Wolcott Daily'
p4
aS'Why Repligen Corporation Shares Are Falling Motley Fool - Nov 6, 2015 What: After reporting third quarter financial results, updating investors on its outlook, and receiving a Wall Street downgrade, shares in Repligen Corporation  tumbled by nearly 20% today. So what: In the third quarter, sales at Repligen&nbsp;...'
p5
aS'Read This Before You Sell Repligen Corporation Stock Motley Fool - Apr 4, 2016 Long-term shareholders of bioprocessing kingpin Repligen Corporation  watched with glee as their shares increased about 1,000% over the five-year period ending last summer.'
p6
aS'Foundation Medicine, Inc. and Repligen Corporation Head to Head Compare CML News - Apr 15, 2017 Repligen Corporation has a substantially higher fundamental rating then Foundation Medicine Inc which has an impact on the head-to-head comparison.'
p7
aS'Repligen Corp. RGEN  Wall Street Journal - Feb 11, 2011 Repligen Corp. RGEN . search. View All companies. AT CLOSE 4:00 PM EDT 04/13/17. $35.35 USD; 0.21 0.60%.'
p8
aS'Repligen Hires Ralf Kuriyel as Senior Vice President of Research &amp; Development GlobeNewswire  - Oct 18, 2016 WALTHAM, Mass., Oct. 18, 2016  -- Repligen Corporation , a life sciences company focused on bioprocessing technology leadership, today announced the appointment of Ralf Kuriyel to the position of Senior Vice&nbsp;...'
p9
aS"What You Must Know About Repligen Corporation's  8% ROE? Simply Wall St - Mar 27, 2017 With a ROE of 8%, Repligen Corporation  could hardly match the performance of its industry, which averaged a ROE of 27.48%."
p10
a.